Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6326
CALL
Arvinas
ARVN
$587M
| $688K | ﹤0.01% |
20,500
+11,700
| +133% | +$497K |
|
6327
CALL
BridgeBio Pharma
BBIO
$15.6B
| $688K | ﹤0.01% |
21,100
-12,700
| -38% | -$387K |
|
6328
CALL
Brixmor Property Group
BRX
$9.2B
| $688K | ﹤0.01% |
53,700
+17,400
| +48% | +$197K |
|
6329
Koppers
KOP
$891M
| $688K | ﹤0.01% |
36,543
+21,039
| +136% | +$320K |
|
6330
Evertec
EVTC
$1.89B
| $687K | ﹤0.01% |
24,444
-100,799
| -80% | -$2.67M |
|
6331
CALL
Kodiak Sciences
KOD
$2.6B
| $687K | ﹤0.01% |
12,700
-6,100
| -32% | -$344K |
|
|
MNR
6332
CALL
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $687K | ﹤0.01% |
47,400
+35,300
| +292% | +$458K |
|
6333
CALL
Akebia Therapeutics
AKBA
$242M
| $686K | ﹤0.01% |
50,500
+26,700
| +112% | +$276K |
|
6334
Apogee Enterprises
APOG
$889M
| $686K | ﹤0.01% |
29,775
-57,664
| -66% | -$1.18M |
|
|
CIVI
6335
DELISTED
Civitas Resources
CIVI
| $686K | ﹤0.01% |
46,324
-18,453
| -28% | -$301K |
|
6336
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.8B
| $686K | ﹤0.01% |
+9,375
| New | +$678K |
|
6337
CALL
Worthington Enterprises
WOR
$2.87B
| $686K | ﹤0.01% |
29,845
+14,760
| +98% | +$263K |
|
|
TVTY
6338
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $686K | ﹤0.01% |
60,620
+41,746
| +221% | +$381K |
|
|
CHMI
6339
Cherry Hill Mortgage Investment Corp
CHMI
$108M
| $684K | ﹤0.01% |
75,887
-18,255
| -19% | -$140K |
|
6340
The Joint Corp
JYNT
$120M
| $684K | ﹤0.01% |
44,788
+28,561
| +176% | +$374K |
|
6341
CEL-SCI Corp
CVM
$26.9M
| $683K | ﹤0.01% |
+1,526
| New | +$626K |
|
6342
PUT
Nordson
NDSN
$17.2B
| $683K | ﹤0.01% |
3,600
+200
| +6% | +$33.9K |
|
|
SAIL
6343
CALL
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $683K | ﹤0.01% |
25,800
+2,700
| +12% | +$55.7K |
|
|
CIZ
6344
DELISTED
VictoryShares Developed Enhanced Volatility Wtd ETF
CIZ
| $683K | ﹤0.01% |
+25,371
| New | +$662K |
|
6345
First Trust Mid Cap Growth AlphaDEX Fund
FNY
$609M
| $682K | ﹤0.01% |
14,243
-11,832
| -45% | -$515K |
|
|
PINC
6346
CALL
DELISTED
Premier
PINC
| $682K | ﹤0.01% |
19,900
+2,000
| +11% | +$65.7K |
|
6347
Innovator Growth-100 Power Buffer ETF January
NJAN
$356M
| $681K | ﹤0.01% |
18,678
-223,537
| -92% | -$7.89M |
|
|
REGI
6348
PUT
DELISTED
Renewable Energy Group, Inc.
REGI
| $681K | ﹤0.01% |
27,500
-27,800
| -50% | -$704K |
|
6349
CALL
Genesco
GCO
$391M
| $680K | ﹤0.01% |
+31,400
| New | +$579K |
|
6350
CALL
NiSource
NI
$20.4B
| $680K | ﹤0.01% |
29,900
-19,500
| -39% | -$470K |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.